Regeneron Pharmaceuticals, Inc. (REGN) Easily Tops Q1 EPS Views

May 3, 2013 6:33 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 EPS of $1.78 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found